z-logo
open-access-imgOpen Access
Detection of del(16q) using the CBFB-MYH11 translocation dual fusion probe
Author(s) -
Doaa F. Temerik,
Walaa T. El-Mahdy,
Ahmed Makboul
Publication year - 2020
Publication title -
hematology/oncology and stem cell therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 22
eISSN - 1658-3876
pISSN - 2589-0646
DOI - 10.1016/j.hemonc.2020.02.001
Subject(s) - chromosomal translocation , fluorescence in situ hybridization , biology , pathology , interphase , cytogenetics , bone marrow , myeloid leukemia , fusion gene , chromosomal abnormality , medicine , karyotype , cancer research , chromosome , genetics , gene
Del(16q) is an uncommon cytogenetic abnormality that can occur in different types of myeloid neoplasms. A small number of cases with del(16q) have been reported. Here, we report del(16q) in an adult patient with acute myelomonocytic leukemia (AMML). Examination of bone marrow aspirate smears and cytochemical stains, and flow cytometric immunophenotyping diagnosed the case as AMML. Fluorescence in situ hybridization (FISH) for inv(16) was performed using the CBFB-MYH11 translocation dual fusion probe. Accidently, FISH analysis revealed a loss of 16q22 in most of the examined interphase cells, indicating the presence of del(16q). The CBFB-MYH11 translocation dual fusion probe can be very helpful in detecting del(16q).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom